Trial Profile
Multidrug Resistance Studies in Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2022
Price :
$35
*
At a glance
- Drugs Valspodar (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 02 Aug 2022 Status changed from active, no longer recruiting to completed.
- 18 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned number of patients changed from 250 to 2034 as reported by ClinicalTrials.gov.